Image Credit: peterschreiber.media / Shutterstock.com A recent JAMA Otolaryngology-Head & Neck Surgery study investigates the risk of incident thyroid cancer among adults diagnosed with type 2 diabetes (T2D) and being treated with either glucagon-like peptide-1 receptor agonists (GLP-1RAs) or other glucose-lowering medications
You may still be eating better, walking more, tracking meals, or taking a medication as prescribed, yet the scale barely moves
Your doctor may recommend spacing out the time when you take each medication to lessen the chances of gastrointestinal issues
For weight management drugs, coverage often hinges on documented obesity or related health issues, such as type 2 diabetes or obstructive sleep apnea
For any combination not listed, the Reconstitution Calculator gives instant results
Some studies report risks of pancreatitis and gallbladder complications with prolonged use